MARKET

GUTS

GUTS

Fractyl Health
NASDAQ
0.8812
+0.0705
+8.70%
After Hours: 0.8589 -0.0223 -2.53% 18:03 11/11 EST
OPEN
0.8205
PREV CLOSE
0.8107
HIGH
0.8910
LOW
0.8001
VOLUME
141.09K
TURNOVER
--
52 WEEK HIGH
29.34
52 WEEK LOW
0.8001
MARKET CAP
11.69M
P/E (TTM)
-0.0656
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: BridgeBio Oncology Therapeutics (BBOT) and Fractyl Health, Inc. (GUTS)
TipRanks · 16h ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 2d ago
Weekly Report: what happened at GUTS last week (1102-1106)?
Weekly Report · 2d ago
Fractyl Health Appoints Michael Wartell to Board
TipRanks · 5d ago
Weekly Report: what happened at GUTS last week (1026-1030)?
Weekly Report · 11/02 09:17
Fractyl Health Expands Revita Patent Portfolio Ahead Of Planned FDA De Novo Submission
Benzinga · 10/30 11:16
Weekly Report: what happened at GUTS last week (1019-1023)?
Weekly Report · 10/26 09:16
Fractyl Health Consensus Price Target Increased by 917.27% to $46.07
NASDAQ · 10/23 08:42
More
About GUTS
Fractyl Health, Inc. is a metabolic therapeutics company. The Company is focused on developing new approaches to the treatment of metabolic diseases, including obesity and type 2 diabetes (T2D). The Company’s lead product candidate, Revita, is designed to remodel the duodenal lining via hydrothermal ablation (i.e. duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease. The Revita clinical program is focused on patients living with obesity who want to maintain their weight loss after GLP-1 drug discontinuation. The Company’s Rejuva platform focuses on developing adeno-associated virus (AAV)-based, locally delivered gene therapies for the treatment of obesity and T2D. The Rejuva platform leverages advanced delivery systems and proprietary screening methods to identify and develop metabolically active gene therapy candidates targeting the pancreas.

Webull offers Fractyl Health Inc stock information, including NASDAQ: GUTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GUTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GUTS stock methods without spending real money on the virtual paper trading platform.